In Reply
- PMID: 28382909
- PMCID: PMC5387855
- DOI: 10.3238/arztebl.2017.0193
In Reply
Comment on
-
Lack of Differentiation.Dtsch Arztebl Int. 2017 Mar 17;114(11):192. doi: 10.3238/arztebl.2017.0192a. Dtsch Arztebl Int. 2017. PMID: 28382906 Free PMC article. No abstract available.
-
Pregabalin: Risk of Addiction and Misuse.Dtsch Arztebl Int. 2017 Mar 17;114(11):192. doi: 10.3238/arztebl.2017.0192b. Dtsch Arztebl Int. 2017. PMID: 28382907 Free PMC article. No abstract available.
-
Consider Ineffectiveness.Dtsch Arztebl Int. 2017 Mar 17;114(11):192-193. doi: 10.3238/arztebl.2017.0192c. Dtsch Arztebl Int. 2017. PMID: 28382908 Free PMC article. No abstract available.
References
-
- Baron R, Binder A, Wasner G. Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–819. - PubMed
-
- Guideline on the clinical development of medicinal products intended for the treatment of pain. 6.2.4. Mixed Pain European Medicines Agency Science Medicines Health. EMA/CHMP/970057/2011. Dezember;
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
